HIV viral load and response to antileishmanial chemotherapy in co-infected patients

AIDS

Volumn 13, Issue 14, 1999, Pages 1921-1925

  Berhe, Nega ^a   Wolday, Dawit ^b   Hailu, Asrat ^a   Abraham, Yodit ^b   Ali, Ahmed ^a   Gebre Michael, Teshome ^a   Desjeux, Philipe ^c   Sönnerborg, Anders ^d   Akuffo, Hannah ^e   Britton, Sven ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b Armed Forces General Hospital Addis Ababa   (Ethiopia)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antimonials; HIV; Leishmania; Viremia

Indexed keywords

ANTILEISHMANIAL AGENT; ANTIMONY; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA DONOVANI; MALE; PRIORITY JOURNAL; SMEAR; TREATMENT OUTCOME; VIRUS LOAD; VIRUS REPLICATION; VISCERAL LEISHMANIASIS;

EID: 0032710944     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199910010-00015     Document Type: Article

References (20)

1. World Health Organization/UNAIDS. Leishmania and HIV in Gridlock. WHO/CTD/LEISH/98.9 Add. I, UNAIDS/98.23. Geneva, Switzerland: World Health Organization; 1998.
2. Desjeux P. Leishmaniasis: public aspects and control. Clin Dermatol 1996, 14:417-423.
3. Reed SG, da Silva JS, Ho JL, et al. Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoa. J Acqir Immune Defic Syndr 1992, 5:666-675.
4. Murray HW, Scavuzzo D, Jacobs JL, et al. In vitro and in vivo activation of human macrophages by interferon-gamma. Studies with normal and AIDS monocytes. J Immunol 1989, 138:2457-2462.
5. + subsets in leishmaniasis. J Cell Biochem 1993, 53:323-328.
6. Maggi E, Mazzetti M, Ravina A, et al. Ability of HIV-1 to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994, 265:244-248.
7. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV-1 infection: new insights. Immunol Today 1994, 15:575-581.
8. Hyjek E, Lischner HW, Hyslop T, et al. Cytokine patterns during progression to AIDS in children with perinatal HIV infection. J Immunol 1995, 155: 4060-4071.
9. Chulay JD, Bryceson ADH. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg 1983, 32: 474-479.
10. Mellors JW, Rinaldo CR, Ghupta P, et al. Prognosis in HIV infection predicted by the quantity of virus in plasma. Science 1996, 272:1267-1270.
11. Nabors CS, Farrel J. Successful chemotherapy in experimental leishmaniasis is influenced by the polarity of T-cell response before treatment. J Infect Dis 1996, 173:979-986.
12. Berhe N, Hailu A, Wolday D, Negese Y, Cennini P, Frommel D. Ethiopian visceral leishmaniasis patients co-infected with HIV. Trans R Soc Trop Med Hyg 1995, 89:205-207.
13. Bentwich Z, Kalinovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995, 16:187-191.
14. Golletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 1996, 157:1271-1278.
15. Hoffman IF, Jere CS, Taylor TE, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999, 13: 487-494.
16. Preiser W, Cacopardo B, Nigro L, et al. Immunological findings in HIV-Leishmania co-infection. Intervirology 1996, 39: 285-288.
17. Cacopardo B, Nigro L, Preiser W, et al. Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg 1996, 90:434-435.
18. Bernier R, Turco SJ, Olivier M, Tremblay M. Activation of HIV-1 in monocytoid cells by the protozoan parasite Leishmania donovani. J Virol 1995, 69:7282-7285.
19. Bernier R, Barbeau B, Tremblay Mj, Olivier M. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kB elements. J Immunol 1998, 160:2881-2888.
20. Wolday D, Berhe N, Akuffo H, Britton S. Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today 1999, 15:181-187.